diltiazem has been researched along with butylated hydroxytoluene in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akima, M; Kato, T; Ohi, N; Ozaki, T; Suzuki, Y; Tamura, K | 2 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
3 other study(ies) available for diltiazem and butylated hydroxytoluene
Article | Year |
---|---|
Novel calcium antagonists with both calcium overload inhibition and antioxidant activity. 1. 2-(3, 5-di-tert-butyl-4-hydroxyphenyl)-3-(aminopropyl)thiazolidinones.
Topics: Animals; Antioxidants; Aorta, Thoracic; Calcium; Calcium Channel Blockers; Glycine max; Heart; In Vitro Techniques; Lipid Peroxidation; Lipoproteins, LDL; Lipoxygenase; Male; Myocardium; Phenols; Rabbits; Rats; Thiazoles; Thiazolidines; Veratridine | 1998 |
Novel calcium antagonists with both calcium overload inhibition and antioxidant activity. 2. Structure-activity relationships of thiazolidinone derivatives.
Topics: Animals; Antioxidants; Aorta; Calcium; Calcium Channels; Calcium Channels, L-Type; Chromatography, High Pressure Liquid; Coronary Circulation; Crystallography, X-Ray; Dogs; Glycine max; In Vitro Techniques; Lipid Peroxidation; Lipoproteins, LDL; Lipoxygenase; Male; Models, Molecular; Muscle, Smooth, Vascular; Myocardium; Phenols; Rabbits; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Thiazolidines | 1999 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |